114 filings
Page 5 of 6
8-K
3ezix6
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
gh028x5vjq
23 May 18
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million
8:30am
8-K
afp2r2 y2
23 May 18
Entry into a Material Definitive Agreement
6:06am
8-K
1ap2n
9 May 18
Cara Therapeutics Reports First Quarter 2018 Financial Results
4:10pm
8-K
pbnkcv x6jvedpxw7ol
15 Mar 18
Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
z3ojrcabul7b0fb4h6j
12 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
ctpx dx1g
2 Nov 17
Cara Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
7i05qctucxqcvy2
4 Aug 17
Departure of Directors or Certain Officers
12:00am
8-K
093lfq f6xfyav1a75ue
3 Aug 17
Cara Therapeutics Reports Second Quarter 2017 Financial Results
12:00am
8-K
llisq bm902uygg0
22 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7fx1vkm1sii5d1r
4 May 17
Cara Therapeutics Reports First Quarter 2017 Financial Results
12:00am
8-K
xsg3t0ek
3 Apr 17
Cara Therapeutics Announces Proposed Offering of Common Stock
12:00am
8-K
zdswubfliljsnq5hcu
28 Mar 17
Cara Therapeutics Announces PositiveTop-Line Data
12:00am
8-K
wfl1ys5g58mh e5
9 Mar 17
Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
m32y64kw
3 Nov 16
Cara Therapeutics Reports Third Quarter 2016 Financial Results
12:00am
8-K
koqz83q0urkgoufk37
4 Aug 16
Cara Therapeutics Reports Second Quarter 2016 Financial Results
12:00am
8-K
pcmb8jhq
16 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vseu44mos22ntel
5 May 16
Cara Therapeutics Reports First Quarter 2016 Financial Results
12:00am
8-K
9mhepauz6vx 9gkga
10 Mar 16
Cara Therapeutics Reports Fourth Quarter and Full Year 2015
12:00am
8-K
u01kmu i7hht
11 Jan 16
Regulation FD Disclosure
12:00am